People · Operator
Named in public records as an officer, director or promoter · active 2024–2024 · Biotech / Pharma
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Curve Biosciences, Inc. | — | Biotech / Pharma | Series B | $17.7M | $134.0M | 2024 |
NATHAN HUNKAPILLER at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside NATHAN HUNKAPILLER on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| CHUBA OYOLU | 1 | 1 |
| SHAN XIANG WANG | 1 | 1 |
| THEMASAP KHAN | 1 | 1 |
| RITISH PATNAIK | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.